Short description
This company is improving the lives of patients suffering from dysfunctions in human metabolism and rare disease.
Description
Avolynt is a clinical stage drug development company based in Research Triangle Park, North Carolina. The Company's mission is to improve the lives of patients suffering from dysfunctions related to human metabolism. Avolynt's team has significant discovery and development experience across the metabolic syndrome, including diabetes, obesity, and nonalcoholic steatohepatitis (NASH). The Company's lead programs are in phase 2 and phase 3.
Total funding
$$3123123
Sign in for full access
Location
Durham, North Carolina, United States, North America
Founded on
January 1, 2015
Non-profit?
No
Acquired?
No
Investors
Absolutely Noaccess
Sign in for full access